Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Investments" stands at -0.2166 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2023.
Takeda Pharmaceutical Co. Ltd.'s second quarter result of -0.0481 Trillion JPY for the item "Investments" represents a decrease of -45.01 percent compared to it's first quarter result.
Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of -0.0481 Trillion JPY for the item "Investments" represents an increase of 35.93 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of -0.2166 Trillion JPY for the item "Investments" represents an increase of 11.08 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.152 Trillion Japanese Yens compared to the value the year prior.
The 1 year change is 0.152 Trillion Japanese Yens.
The 3 year change is -0.2324 Trillion Japanese Yens.
The 5 year change is -0.1878 Trillion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Investments | 905,699,262,464.00 |
![]() | Johnson & Johnson - Investments | 486,508,953,600.00 |
![]() | AbbVie Inc - Investments | 399,570,305,024.00 |
![]() | Roche Holding AG - Investments | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Investments | 280,205,508,085.11 |